The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Artificial Intelligence Drug R&D Market Research Report 2025

Global Artificial Intelligence Drug R&D Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1912848

No of Pages : 96

Ask Your Query

Synopsis

Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.

The global Artificial Intelligence Drug R&D market was valued at US$ 617 million in 2023 and is anticipated to reach US$ 1081.1 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug R&D.

Report Scope

The Artificial Intelligence Drug R&D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Drug R&D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Artificial Intelligence Drug R&D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • IBM Watson
  • BioXel
  • Insilico Medicine
  • Gatehouse Bio
  • Google DeepMind
  • Genpact Cora
  • Cyclica Inc
  • QuantumBlack
  • Nq Medical
  • Phenomic AI
  • Palantir Technologies
  • BenevolentAI
  • Atomwise
  • Numerate
  • Recursion Pharmaceuticals
  • Exscientia
  • TwoXAR
  • AiCure

Segment by Type

  • AI Platfrom
  • Analytics Service
  • Segment by Application
  • Drug Discovery
  • Precision Medicine

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Drug R&D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 AI Platfrom
1.2.3 Analytics Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug R&D Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Precision Medicine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug R&D Market Perspective (2019-2030)
2.2 Artificial Intelligence Drug R&D Growth Trends by Region
2.2.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence Drug R&D Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence Drug R&D Market Dynamics
2.3.1 Artificial Intelligence Drug R&D Industry Trends
2.3.2 Artificial Intelligence Drug R&D Market Drivers
2.3.3 Artificial Intelligence Drug R&D Market Challenges
2.3.4 Artificial Intelligence Drug R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2023
3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug R&D Breakdown Data by Type
4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Drug R&D Breakdown Data by Application
5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence Drug R&D Market Size (2019-2030)
6.2 North America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug R&D Market Size (2019-2030)
7.2 Europe Artificial Intelligence Drug R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug R&D Market Size (2019-2030)
9.2 Latin America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM Watson
11.1.1 IBM Watson Company Detail
11.1.2 IBM Watson Business Overview
11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.1.5 IBM Watson Recent Development
11.2 BioXel
11.2.1 BioXel Company Detail
11.2.2 BioXel Business Overview
11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.2.5 BioXel Recent Development
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Detail
11.3.2 Insilico Medicine Business Overview
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.3.5 Insilico Medicine Recent Development
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Detail
11.4.2 Gatehouse Bio Business Overview
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.4.5 Gatehouse Bio Recent Development
11.5 Google DeepMind
11.5.1 Google DeepMind Company Detail
11.5.2 Google DeepMind Business Overview
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.5.5 Google DeepMind Recent Development
11.6 Genpact Cora
11.6.1 Genpact Cora Company Detail
11.6.2 Genpact Cora Business Overview
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.6.5 Genpact Cora Recent Development
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Detail
11.7.2 Cyclica Inc Business Overview
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.7.5 Cyclica Inc Recent Development
11.8 QuantumBlack
11.8.1 QuantumBlack Company Detail
11.8.2 QuantumBlack Business Overview
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.8.5 QuantumBlack Recent Development
11.9 Nq Medical
11.9.1 Nq Medical Company Detail
11.9.2 Nq Medical Business Overview
11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.9.5 Nq Medical Recent Development
11.10 Phenomic AI
11.10.1 Phenomic AI Company Detail
11.10.2 Phenomic AI Business Overview
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.10.5 Phenomic AI Recent Development
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Detail
11.11.2 Palantir Technologies Business Overview
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.11.5 Palantir Technologies Recent Development
11.12 BenevolentAI
11.12.1 BenevolentAI Company Detail
11.12.2 BenevolentAI Business Overview
11.12.3 BenevolentAI Artificial Intelligence Drug R&D Introduction
11.12.4 BenevolentAI Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.12.5 BenevolentAI Recent Development
11.13 Atomwise
11.13.1 Atomwise Company Detail
11.13.2 Atomwise Business Overview
11.13.3 Atomwise Artificial Intelligence Drug R&D Introduction
11.13.4 Atomwise Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.13.5 Atomwise Recent Development
11.14 Numerate
11.14.1 Numerate Company Detail
11.14.2 Numerate Business Overview
11.14.3 Numerate Artificial Intelligence Drug R&D Introduction
11.14.4 Numerate Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.14.5 Numerate Recent Development
11.15 Recursion Pharmaceuticals
11.15.1 Recursion Pharmaceuticals Company Detail
11.15.2 Recursion Pharmaceuticals Business Overview
11.15.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Introduction
11.15.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.15.5 Recursion Pharmaceuticals Recent Development
11.16 Exscientia
11.16.1 Exscientia Company Detail
11.16.2 Exscientia Business Overview
11.16.3 Exscientia Artificial Intelligence Drug R&D Introduction
11.16.4 Exscientia Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.16.5 Exscientia Recent Development
11.17 TwoXAR
11.17.1 TwoXAR Company Detail
11.17.2 TwoXAR Business Overview
11.17.3 TwoXAR Artificial Intelligence Drug R&D Introduction
11.17.4 TwoXAR Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.17.5 TwoXAR Recent Development
11.18 AiCure
11.18.1 AiCure Company Detail
11.18.2 AiCure Business Overview
11.18.3 AiCure Artificial Intelligence Drug R&D Introduction
11.18.4 AiCure Revenue in Artificial Intelligence Drug R&D Business (2019-2024)
11.18.5 AiCure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of AI Platfrom
Table 3. Key Players of Analytics Service
Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Artificial Intelligence Drug R&D Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Artificial Intelligence Drug R&D Market Share by Region (2019-2024)
Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Artificial Intelligence Drug R&D Market Share by Region (2025-2030)
Table 10. Artificial Intelligence Drug R&D Market Trends
Table 11. Artificial Intelligence Drug R&D Market Drivers
Table 12. Artificial Intelligence Drug R&D Market Challenges
Table 13. Artificial Intelligence Drug R&D Market Restraints
Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2019-2024)
Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2023)
Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artificial Intelligence Drug R&D Product Solution and Service
Table 21. Date of Enter into Artificial Intelligence Drug R&D Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2019-2024)
Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2025-2030)
Table 27. Global Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2019-2024)
Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2025-2030)
Table 31. North America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Artificial Intelligence Drug R&D Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Artificial Intelligence Drug R&D Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Artificial Intelligence Drug R&D Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2025-2030) & (US$ Million)
Table 46. IBM Watson Company Detail
Table 47. IBM Watson Business Overview
Table 48. IBM Watson Artificial Intelligence Drug R&D Product
Table 49. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 50. IBM Watson Recent Development
Table 51. BioXel Company Detail
Table 52. BioXel Business Overview
Table 53. BioXel Artificial Intelligence Drug R&D Product
Table 54. BioXel Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 55. BioXel Recent Development
Table 56. Insilico Medicine Company Detail
Table 57. Insilico Medicine Business Overview
Table 58. Insilico Medicine Artificial Intelligence Drug R&D Product
Table 59. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 60. Insilico Medicine Recent Development
Table 61. Gatehouse Bio Company Detail
Table 62. Gatehouse Bio Business Overview
Table 63. Gatehouse Bio Artificial Intelligence Drug R&D Product
Table 64. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 65. Gatehouse Bio Recent Development
Table 66. Google DeepMind Company Detail
Table 67. Google DeepMind Business Overview
Table 68. Google DeepMind Artificial Intelligence Drug R&D Product
Table 69. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 70. Google DeepMind Recent Development
Table 71. Genpact Cora Company Detail
Table 72. Genpact Cora Business Overview
Table 73. Genpact Cora Artificial Intelligence Drug R&D Product
Table 74. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 75. Genpact Cora Recent Development
Table 76. Cyclica Inc Company Detail
Table 77. Cyclica Inc Business Overview
Table 78. Cyclica Inc Artificial Intelligence Drug R&D Product
Table 79. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 80. Cyclica Inc Recent Development
Table 81. QuantumBlack Company Detail
Table 82. QuantumBlack Business Overview
Table 83. QuantumBlack Artificial Intelligence Drug R&D Product
Table 84. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 85. QuantumBlack Recent Development
Table 86. Nq Medical Company Detail
Table 87. Nq Medical Business Overview
Table 88. Nq Medical Artificial Intelligence Drug R&D Product
Table 89. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 90. Nq Medical Recent Development
Table 91. Phenomic AI Company Detail
Table 92. Phenomic AI Business Overview
Table 93. Phenomic AI Artificial Intelligence Drug R&D Product
Table 94. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 95. Phenomic AI Recent Development
Table 96. Palantir Technologies Company Detail
Table 97. Palantir Technologies Business Overview
Table 98. Palantir Technologies Artificial Intelligence Drug R&D Product
Table 99. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 100. Palantir Technologies Recent Development
Table 101. BenevolentAI Company Detail
Table 102. BenevolentAI Business Overview
Table 103. BenevolentAI Artificial Intelligence Drug R&D Product
Table 104. BenevolentAI Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 105. BenevolentAI Recent Development
Table 106. Atomwise Company Detail
Table 107. Atomwise Business Overview
Table 108. Atomwise Artificial Intelligence Drug R&D Product
Table 109. Atomwise Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 110. Atomwise Recent Development
Table 111. Numerate Company Detail
Table 112. Numerate Business Overview
Table 113. Numerate Artificial Intelligence Drug R&D Product
Table 114. Numerate Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 115. Numerate Recent Development
Table 116. Recursion Pharmaceuticals Company Detail
Table 117. Recursion Pharmaceuticals Business Overview
Table 118. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product
Table 119. Recursion Pharmaceuticals Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 120. Recursion Pharmaceuticals Recent Development
Table 121. Exscientia Company Detail
Table 122. Exscientia Business Overview
Table 123. Exscientia Artificial Intelligence Drug R&D Product
Table 124. Exscientia Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 125. Exscientia Recent Development
Table 126. TwoXAR Company Detail
Table 127. TwoXAR Business Overview
Table 128. TwoXAR Artificial Intelligence Drug R&D Product
Table 129. TwoXAR Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 130. TwoXAR Recent Development
Table 131. AiCure Company Detail
Table 132. AiCure Business Overview
Table 133. AiCure Artificial Intelligence Drug R&D Product
Table 134. AiCure Revenue in Artificial Intelligence Drug R&D Business (2019-2024) & (US$ Million)
Table 135. AiCure Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence Drug R&D Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Artificial Intelligence Drug R&D Market Share by Type: 2023 VS 2030
Figure 3. AI Platfrom Features
Figure 4. Analytics Service Features
Figure 5. Global Artificial Intelligence Drug R&D Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Artificial Intelligence Drug R&D Market Share by Application: 2023 VS 2030
Figure 7. Drug Discovery Case Studies
Figure 8. Precision Medicine Case Studies
Figure 9. Artificial Intelligence Drug R&D Report Years Considered
Figure 10. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Artificial Intelligence Drug R&D Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Artificial Intelligence Drug R&D Market Share by Region: 2023 VS 2030
Figure 13. Global Artificial Intelligence Drug R&D Market Share by Players in 2023
Figure 14. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2023
Figure 16. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Artificial Intelligence Drug R&D Market Share by Country (2019-2030)
Figure 18. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Artificial Intelligence Drug R&D Market Share by Country (2019-2030)
Figure 22. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2019-2030)
Figure 30. China Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Artificial Intelligence Drug R&D Market Share by Country (2019-2030)
Figure 38. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2019-2030)
Figure 42. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 45. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 46. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 47. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 48. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 49. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 50. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 51. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 52. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 53. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 54. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 55. BenevolentAI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 56. Atomwise Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 57. Numerate Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 58. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 59. Exscientia Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 60. TwoXAR Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 61. AiCure Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Latest IT & Electronics Market Reports

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock